Recalls
Searchable archive of product recalls from the FDA, USDA FSIS, CPSC, NHTSA, and EPA — translated into plain English, severity-scored from objective criteria, and always linked back to the original government notice.
Every recall on this list has been scored 1–5 against an objective rubric from the agency’s own classification, presence of reported injuries or deaths, distribution scope, and hazard type. The colored severity badge on each card is the score — 5 (Critical) means deaths or serious injuries are reported, 4 (Severe) means significant injury or hospitalization risk, and 3 (High) means a known hazard with no confirmed harm yet. Filter to 3+ (High and above) if you want to skip routine Class-III notices.
The agency chips above control which streams are visible. FDA spans food, drugs, and medical devices. USDA FSIS is meat, poultry, and processed egg products. CPSC is household consumer products. NHTSA is vehicles, tires, and child seats. Nationwide on a card means the recall affects every US state — most do — while a state list means distribution was limited.
Click any recall to see the full summary, affected lot codes and model numbers, the agency’s own classification, and a direct link back to the original government notice for verification.
Minimum severity
Assurance Infusion is recalling BUP 4MG/FENT 3000MCG/ML Injection in 20 mL syringes due to a lack of sterility assurance.
Assurance Infusion is recalling BUP 15MG/CLON 400MCG/ FENT 6000MCG/ML INJ in 20 mL syringes due to a lack of sterility assurance.
Assurance Infusion is recalling specific lots of Buprenorphine and Hydromorphone injection due to a lack of sterility assurance.
Assurance Infusion is recalling specific lots of Testosterone Cypionate 200mg/mL oil due to a lack of sterility assurance. The affected vials were distributed nationwide.
Assurance Infusion is recalling BUP 675MCG/MORP 20MG/ML Injection syringes due to a lack of sterility assurance.
Assurance Infusion is recalling specific lots of Hydromorphone 2mg/mL injection syringes because of a lack of sterility assurance.
Assurance Infusion is recalling specific syringes of Baclofen, Fentanyl, and Morphine injection due to a lack of sterility assurance.
Assurance Infusion is recalling a specific lot of BUP 20MG/CLON 300MCG/FENT 2000MCG/ML Injection due to a lack of sterility assurance.
Assurance Infusion is recalling BUP 23MG/HYDROM 25MG/SUF 100MCG/ML Injection syringes due to a lack of sterility assurance. The recall covers nationwide distribution.
Assurance Infusion is recalling LIPO B 25MG/50MG/50MG/1000MCG/ML products due to a lack of sterility assurance. The recall covers nationwide distribution.
Assurance Infusion is recalling Hydromorphone 15mg/mL injection syringes due to a lack of sterility assurance. The product was distributed nationwide.
Assurance Infusion is recalling specific lots of Morphine 7mg/mL injection syringes due to a lack of sterility assurance. The product was distributed nationwide.
Assurance Infusion is recalling BUP 17MG/MORP 22MG/ML injection syringes due to a lack of sterility assurance.
Assurance Infusion is recalling 1,290 vials of TRIMIX injection nationwide due to a lack of sterility assurance. No specific illnesses or injuries are reported in the source text.
Assurance Infusion is recalling Morphine 4mg/mL Injection in 20mL syringes due to lack of sterility assurance. The recall affects specific lots distributed nationwide.
Sigan Industries is recalling Eczema Skin Relief Lotion due to microbial contamination. The product was distributed in Illinois.
McGuff Compounding Pharmacy Services is recalling Lipoic Acid Injection vials because filmy or cloudy particulate matter was observed in the product.
Sun Pharmaceutical Industries is recalling Testosterone Cypionate for Injection due to cGMP deviations and similarity to a previously rejected lot.
Letco Medical LLC is voluntarily recalling subpotent Estriol USP Micronized products distributed in the US and internationally.
Wisconsin Pharmacal Company is voluntarily recalling 44,373 cartons of Yeast Arrest vaginal suppositories due to current Good Manufacturing Practice (cGMP) violations.
Sun Pharmaceutical Industries is recalling specific lots of Sumatriptan Succinate 50 mg tablets because they failed impurity specifications.
Lupin Pharmaceuticals is recalling specific lots of Tri-Lo-Marzia oral contraceptives due to out-of-specification test results found during a retrospective review of blend uniformity data.
AuroMedics Pharma LLC is recalling Moxifloxacin Ophthalmic Solution due to market complaints of discoloration. The affected product is distributed nationwide in the U.S.
Asclemed USA Inc. dba Enovachem Pharmaceuticals is recalling Estriol, USP, (Micronized), 0.06 g, due to out-of-specification impurity test results.
Appco Pharma LLC is recalling specific lots of Ranitidine Capsules 150 mg because the active ingredient contained the impurity N-nitrosodimethylamine (NDMA).